trial · primary record
Maridebart cafraglutide
Obesity
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 180 |
| Primary completion | 2028-02-25 |
| Primary endpoint | Area Under the Plasma Concentration-time Curve Over a Dosing Interval (AUCtau) of Maridebart Cafraglutide |
| Registry ID | NCT07908316 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:44.918Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908316
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Maridebart cafraglutide · compound